For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210401:nBw1L7yNGa&default-theme=true
FORM 8.3 - WILLIS TOWERS WATSON PLC
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 31 March 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,773,973 1.38% 190,301 0.15%
(2) Derivatives (other than options):
102,359 0.08% 7,066 0.01%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
(4) TOTAL:
1,882,432 1.46% 203,467 0.16%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 4 229.6500 USD
Purchase 13 229.5400 USD
Purchase 14 230.1628 USD
Purchase 16 230.4893 USD
Purchase 30 229.7313 USD
Purchase 32 230.0350 USD
Purchase 55 229.8284 USD
Purchase 58 230.1282 USD
Purchase 60 230.1621 USD
Purchase 67 230.9545 USD
Purchase 80 229.4520 USD
Purchase 80 230.2510 USD
Purchase 81 230.0872 USD
Purchase 87 229.4667 USD
Purchase 89 230.2313 USD
Purchase 90 230.1737 USD
Purchase 91 229.5369 USD
Purchase 98 229.5215 USD
Purchase 100 230.3139 USD
Purchase 104 229.5672 USD
Purchase 108 229.6728 USD
Purchase 118 229.8454 USD
Purchase 122 230.1952 USD
Purchase 127 229.3987 USD
Purchase 141 228.8841 USD
Purchase 157 231.4218 USD
Purchase 195 230.3582 USD
Purchase 400 230.0550 USD
Purchase 600 229.7841 USD
Purchase 600 230.7150 USD
Purchase 667 229.7760 USD
Purchase 719 229.5278 USD
Purchase 739 230.7087 USD
Purchase 890 230.1356 USD
Purchase 1,723 231.1736 USD
Purchase 1,957 230.7135 USD
Purchase 2,089 229.4919 USD
Purchase 2,506 230.1002 USD
Purchase 2,585 229.7057 USD
Purchase 2,621 231.0747 USD
Purchase 3,106 229.1179 USD
Purchase 3,465 229.8535 USD
Purchase 4,331 230.6815 USD
Purchase 5,058 230.1223 USD
Purchase 6,564 230.2552 USD
Purchase 13,467 228.8800 USD
Purchase 35,591 229.5541 USD
Sale 1 229.4700 USD
Sale 4 229.6500 USD
Sale 40 229.1100 USD
Sale 100 230.7800 USD
Sale 100 230.6900 USD
Sale 229 231.8270 USD
Sale 244 229.3830 USD
Sale 1,483 231.2884 USD
Sale 1,780 230.1356 USD
Sale 2,270 229.9417 USD
Sale 3,660 229.0388 USD
Sale 4,761 230.4526 USD
Sale 5,013 230.1822 USD
Sale 5,165 229.8169 USD
Sale 6,848 230.3999 USD
Sale 10,000 230.7982 USD
Sale 14,367 228.8800 USD
Sale 36,590 229.4444 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 1 Apr 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210401005507/en/
(https://www.businesswire.com/news/home/20210401005507/en/)
BARCLAYS PLC
Copyright Business Wire 2021